about
A new approach to reducing postsurgical cancer recurrence: perioperative targeting of catecholamines and prostaglandinsWelfare Assessment following Heterotopic or Orthotopic Inoculation of Bladder Cancer in C57BL/6 MiceExploiting the critical perioperative period to improve long-term cancer outcomesThe effect of β-adrenergic blockade and COX-2 inhibition on healing of colon, muscle, and skin in rats undergoing colonic anastomosis.Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2.Inhibition of cyclo-oxygenase 2 reduces tumor metastasis and inflammatory signaling during blockade of vascular endothelial growth factor.Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvementCyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer.Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis.Perioperative administration of propranolol to women undergoing ovarian cancer surgery: A pilot study.Systems biology: a therapeutic target for tumor therapy.Analgesics promote welfare and sustain tumour growth in orthotopic 4T1 and B16 mouse cancer models.Effects of propofol-based total intravenous anesthesia on gastric cancer: a retrospective study.Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow.
P2860
Q27021528-DC4084EE-478C-4236-891D-29EBB6019D6FQ28553155-9D7BF05B-96AF-493C-9028-2550339142C1Q33871661-1CADF81F-A0B0-4A7E-9D09-39522D30B17AQ35148963-58EF6252-2615-4963-88EF-186987D657EEQ35289963-22E0BD27-B7BB-4F55-8F47-9942DF81952CQ35413008-890D53CE-959F-4B21-8999-73088957D100Q36177081-6347A8FD-D5EB-4D6B-8CDF-726E10C32265Q36609908-E010B624-52ED-4652-A793-4C740D0CDA12Q37412219-6769FDAC-6445-4389-8DC2-E10AA9EBC4F5Q37718895-323CCFF9-05C5-4442-9A38-1B1456FEE702Q41961938-CBFC17C6-5A50-4322-AAE0-68B5E7BB9397Q47224125-7CDAE71C-DD33-408A-9649-A2F5DBC19003Q55023619-9F8C91C8-7517-4E86-AEF8-84EE1BF238DEQ55364776-F4DDC0F6-BEBD-4D8F-849E-30F11E74CA2E
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Antimetastatic activity of a cyclooxygenase-2 inhibitor
@ast
Antimetastatic activity of a cyclooxygenase-2 inhibitor
@en
Antimetastatic activity of a cyclooxygenase-2 inhibitor
@nl
type
label
Antimetastatic activity of a cyclooxygenase-2 inhibitor
@ast
Antimetastatic activity of a cyclooxygenase-2 inhibitor
@en
Antimetastatic activity of a cyclooxygenase-2 inhibitor
@nl
prefLabel
Antimetastatic activity of a cyclooxygenase-2 inhibitor
@ast
Antimetastatic activity of a cyclooxygenase-2 inhibitor
@en
Antimetastatic activity of a cyclooxygenase-2 inhibitor
@nl
P2093
P2860
P3181
P356
P1476
Antimetastatic activity of a cyclooxygenase-2 inhibitor
@en
P2093
D J Bouchier-Hayes
E M Connolly
G Roche-Nagle
J H Harmey
P2860
P2888
P304
P3181
P356
10.1038/SJ.BJC.6601967
P407
P577
2004-07-19T00:00:00Z
P5875
P6179
1041994889